Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-004917
Filing Date
2025-01-21
Accepted
2025-01-21 16:30:14
Documents
2
Period of Report
2025-01-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm253995-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm253995-1_3seq1.xml 3 1610
2 EXHIBIT 24 tm253995d1_ex24.htm EX-24 6076
  Complete submission text file 0001104659-25-004917.txt   9148
Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Issuer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O EPIZYME, INC. 400 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address
Ros Matthew (Reporting) CIK: 0001673802 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35403 | Film No.: 25542852